Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2026-03-06 00:00:00 ET · period of report 2026-03-04 · accession 0001104659-26-024750 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-06 | 2026-03-04 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | S - Sale+OE | $89.56 | -5,614 | 160 | -97% | -$502.8K |
| D | 2026-03-06 | 2026-03-04 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | $17.97 | +1,500 | 5,753 | +35% | +$27.0K |
| D | 2026-03-06 | 2026-03-04 | RYTM | German Christopher Paul | CAO, Corp. Ctrl | M - OptEx | $0.00 | -1,500 | 3,731 | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-04 | S | D | 5,614 | $89.56 | 160 | D | — | — | (F1) Includes 21 shares of Common Stock purchased pursuant to the Rhythm Pharmaceuticals, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-03-04 | M | A | 1,500 | $17.97 | 5,753 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2026-03-04 | M | D | 1,500 | $0.00 | 3,731 | D | $17.97 · — to 2033-04-03 | 1,500 Common Stock | (F2) The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. |